News

Researchers have discovered a mechanism involving the MBNL1 protein that predicts several characteristics of cancer including progression and relapse.

Gliomas with mutations in isocitrate dehydrogenase genes are the most common brain tumors diagnosed in younger adults. Now a team has devised a potentially promising strategy to target these tumors and improve treatment.

A team of scientists has designed a novel catalytic method that can generate useful chiral compounds. This new strategy could provide an effective synthetic way to design pharmaceutical products.

Researchers have discovered a library of molecules with unique structural and chemical features, capable of inhibiting the SARS-CoV-2 polymerase.

UCLA bioengineers have designed a glove-like device that can translate American Sign Language into English speech in real time though a smartphone app. Their research is published in the journal Nature Electronics.

A team has analyzed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins in its target cells. The scientists have also identified seven existing drugs that could disrupt these mechanisms.

Researchers have developed a novel system that can effectively measure brain activity in multiple adult zebrafish simultaneously, opening doors to faster and low-cost testing of drugs for neurological diseases.

Researchers have designed a potential new treatment for one of the most common forms of muscular dystrophy, according to a new study published in the Proceedings of the National Academy of Sciences.

By folding DNA into a virus-like structure, MIT researchers have designed HIV-like particles that provoke a strong immune response from human immune cells grown in a lab dish. Such particles might eventually be used as an HIV vaccine.

Yale Cancer Center scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer.